Analysts Set Immuneering Co. (NASDAQ:IMRX) Target Price at $12.20
Immuneering Co. (NASDAQ:IMRX – Get Free Report) has received a consensus recommendation of “Hold” from the seven research firms that are currently covering the stock, Marketbeat.com reports. One investment analyst has rated the stock with a sell recommendation, three have assigned a hold recommendation and three have issued a buy recommendation on the company. The […]
Immuneering Co. (NASDAQ:IMRX – Get Free Report) has received a consensus recommendation of “Hold” from the seven research firms that are currently covering the stock, Marketbeat.com reports. One investment analyst has rated the stock with a sell recommendation, three have assigned a hold recommendation and three have issued a buy recommendation on the company. The […]
